vancomycin has been researched along with gallic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Brackman, G; Coenye, T; Risseeuw, MDP; Van Calenbergh, S; Vermote, A | 1 |
| Campbell, M; Cho, CY; Gilbert, ES; Ho, A; Huang, JY; Martin, B | 1 |
3 other study(ies) available for vancomycin and gallic acid
| Article | Year |
|---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Design, synthesis and biological evaluation of novel hamamelitannin analogues as potentiators for vancomycin in the treatment of biofilm related Staphylococcus aureus infections.
Topics: Anti-Bacterial Agents; Biofilms; Drug Design; Gallic Acid; Hexoses; Humans; Microbial Sensitivity Tests; Quorum Sensing; Staphylococcal Infections; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2016 |
4-Ethoxybenzoic acid inhibits Staphylococcus aureus biofilm formation and potentiates biofilm sensitivity to vancomycin.
Topics: Anti-Bacterial Agents; Biofilms; Drug Synergism; Drug Therapy, Combination; Gallic Acid; Humans; Hydrophobic and Hydrophilic Interactions; Hydroxybenzoate Ethers; Staphylococcus aureus; Structure-Activity Relationship; Vancomycin | 2020 |